Letter: infliximab concentrations during induction therapy-one size does not fit all

被引：5

作者：

Papamichael, K. ^{[1
]}

Cheifetz, A. S. ^{[1
]}

机构：

[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Inflammatory Bowel Dis, Div Gastroenterol, Boston, MA 02115 USA

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 47卷 / 09期

关键词：

ULCERATIVE-COLITIS; ANTIBODY-LEVELS; CROHNS-DISEASE; PREDICTION; OUTCOMES; DRUG;

D O I：

10.1111/apt.14616

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1334 / 1335

页数：2

共 10 条

[1] Association Between Serum Concentration of Infliximab and Efficacy in Adult Patients With Ulcerative Colitis [J].

Adedokun, Omoniyi J. ;

Sandborn, William J. ;

Feagan, Brian G. ;

Rutgeerts, Paul ;

Xu, Zhenhua ;

Marano, Colleen W. ;

Johanns, Jewel ;

Zhou, Honghui ;

Davis, Hugh M. ;

Cornillie, Freddy ;

Reinisch, Walter .

GASTROENTEROLOGY, 2014, 147 (06) :1296-+

[2] Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy [J].

Bar-Yoseph, H. ;

Levhar, N. ;

Selinger, L. ;

Manor, U. ;

Yavzori, M. ;

Picard, O. ;

Fudim, E. ;

Kopylov, U. ;

Eliakim, R. ;

Ben-Horin, S. ;

Chowers, Y. ;

Ungar, B. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (02) :212-218

[3] Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis [J].

Brandse, Johannan F. ;

Mathot, Ron A. ;

van der Kleij, Desiree ;

Rispens, Theo ;

Ashruf, Yael ;

Jansen, Jeroen M. ;

Rietdijk, Svend ;

Lowenberg, Mark ;

Ponsioen, Cyriel Y. ;

Singh, Sharat ;

van den Brink, Gijs R. ;

D'Haens, Geert R. .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (02) :251-+

[4] Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn's Disease [J].

Davidov, Yana ;

Ungar, Bella ;

Bar-Yoseph, Haggai ;

Carter, Dan ;

Haj-Natour, Ola ;

Yavzori, Miri ;

Chowers, Yehuda ;

Eliakim, Rami ;

Ben-Horin, Shomron ;

Kopylov, Uri .

JOURNAL OF CROHNS & COLITIS, 2017, 11 (05) :549-555

[5]

Dreesen E, 2018, J CROHNS COLITIS, V12, pS63

[6] Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role? [J].

Gonczi, Lorant ;

Vegh, Zsuzsanna ;

Golovics, Petra Anna ;

Rutka, Mariann ;

Gecse, Krisztina Barbara ;

Bor, Renata ;

Farkas, Klaudia ;

Szamosi, Tamas ;

Bene, Laszlo ;

Gasztonyi, Beata ;

Kristof, Tunde ;

Lakatos, Laszlo ;

Miheller, Pal ;

Palatka, Karoly ;

Papp, Maria ;

Patai, Arpad ;

Salamon, Agnes ;

Toth, Gabor Tamas ;

Vincze, Aron ;

Biro, Edina ;

Lovasz, Barbara Dorottya ;

Kurti, Zsuzsanna ;

Szepes, Zoltan ;

Molnar, Tamas ;

Lakatos, Peter L. .

JOURNAL OF CROHNS & COLITIS, 2017, 11 (06) :697-705

[7] First trough level of infliximab at week 2 predicts future outcomes of induction therapy in ulcerative colitis-results from a multicenter prospective randomized controlled trial and its post hoc analysis [J].

Kobayashi, Taku ;

Suzuki, Yasuo ;

Motoya, Satoshi ;

Hirai, Fumihito ;

Ogata, Haruhiko ;

Ito, Hiroaki ;

Sato, Noriko ;

Ozaki, Kunihiko ;

Watanabe, Mamoru ;

Hibi, Toshifumi .

JOURNAL OF GASTROENTEROLOGY, 2016, 51 (03) :241-251

[8] Therapeutic Drug Monitoring During Induction of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: Defining a Therapeutic Drug Window [J].

Papamichael, Konstantinos ;

Vande Casteele, Niels ;

Ferrante, Marc ;

Gils, Ann ;

Cheifetz, Adam S. .

INFLAMMATORY BOWEL DISEASES, 2017, 23 (09) :1510-1515

[9] Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis [J].

Papamichael, Konstantinos ;

Van Stappen, Thomas ;

Casteele, Niels Vande ;

Gils, Ann ;

Billiet, Thomas ;

Tops, Sophie ;

Claes, Karolien ;

Van Assche, Gert ;

Rutgeerts, Paul ;

Vermeire, Severine ;

Ferrante, Marc .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (04) :543-549

[10] Antibody Response to Infliximab and its Impact on Pharmacokinetics can be Transient [J].

Vande Casteele, Niels ;

Gils, Ann ;

Singh, Sharat ;

Ohrmund, Linda ;

Hauenstein, Scott ;

Rutgeerts, Paul ;

Vermeire, Severine .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06) :962-971

← 1 →